ADVFN - Advanced Financial Network.
HOME» NASDAQ » G » GILD Stock Price » GILD Stock News

Gilead Sciences Share News

 Gilead Sciences (mm) Stock Price
GILD Stock Price
 Gilead Sciences (mm) Stock Chart
GILD Stock Chart
 Gilead Sciences (mm) Stock News
GILD Stock News
 Gilead Sciences (mm) Company Information
GILD Company Information
 Gilead Sciences (mm) Stock Trades
GILD Stock Trades

Gilead Sciences to Promote Low-Cost HIV Medicine in Developing World

By Chelsea Stevenson Gilead Sciences Inc. (GILD) said it plans to partner with Mylan Inc. (MYL), Ranbaxy Laboratories Ltd. (500359.BY) and Strides Arcolab Ltd. (532531.BY) to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries. The medicine includes single tablet regimens and fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines. Under the new agreement, Gilead will provide a technology transfer for the manufacture of emtricitabine as well as funding to reduce overall manufacturing costs. Emtricitabine is marked by Gilead under the name Emtriva and the fixed-dose is available under the name Truvada. But costs are an obstacle for high-volume production. More than 2.7 million patients living with HIV in developing countries are currently receiving a medicine innovated by Gilead and subsequently licensed to Indian generic partners, as part of the company's efforts to increase global access. Strides Arcolab Managing Director Arun Kumar said the partnership will also re-enforce commitments to provide affordable drugs in the tuberculosis and malaria fields. Gilead's second-quarter earnings slid last week as the company posted a double-digit increase in costs, which offset its strong revenue growth. Earlier this year, the company bought Pharmasset Inc. for more than $11 billion, expecting the company to help accelerate the development of treatments for hepatitis C. Write to Chelsea Stevenson at chelsea.stevenson@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Gilead Sciences (GILD)
DateTimeHeadline
04/18/201515:02:033 Drug Stocks Leading the Charge Against Infectious Diseases
04/18/201510:02:03What Could Possibly Go Wrong With Gilead Sciences Inc. Stock?
04/17/201514:24:26Statement of Changes in Beneficial Ownership (4)
04/17/201506:04:06Notice of Exempt Solicitation. Definitive Material. (px14a6g)
04/16/201511:59:10Johnson & Johnson's Earnings: The Good, The Bad and The Ugly
04/16/201508:03:02The Best Stock to Invest in Hep C
04/13/201513:59:023 Stocks You Absolutely Must Watch This Earnings Season
04/12/201521:15:47Perennial Dividend Champion Johnson & Johnson To Report On Tuesday
04/12/201505:34:07401(K) Reconstructed: 2015 Q1 Review
04/11/201515:02:0310 Largest Companies by Market Cap in Biotech
04/11/201508:07:03The 3 Best Stocks to Invest in Biotechnology
04/09/201517:59:09Why Investors Shouldn't Worry About Explosive New Drug Pricing:...
04/09/201516:41:55Statement of Changes in Beneficial Ownership (4)
04/09/201516:41:27Statement of Changes in Beneficial Ownership (4)
04/09/201501:28:13Is Biogen A Buy? An Analysis Of Its Growth Drivers And Challenges
04/08/201521:01:00Gilead reicht Zulassungsantrag für neues Medikament mit Festdosiskombination...
04/08/201515:30:00Gilead soumet une Demande de drogue nouvelle auprès de la U.S...
04/08/201513:19:07Chasing - And Surviving - Today's Income Storm
04/07/201522:00:00Gilead deposita una domanda di approvazione di nuovo farmaco...
04/07/201517:56:00Gilead Submits New Drug Application to U.S. Food & Drug Administration...

Gilead Sciences and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad